Aro Biotherapeutics Revenue and Competitors

Location

$101M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Aro Biotherapeutics's estimated annual revenue is currently $4.3M per year.(i)
  • Aro Biotherapeutics's estimated revenue per employee is $77,500
  • Aro Biotherapeutics's total funding is $101M.

Employee Data

  • Aro Biotherapeutics has 56 Employees.(i)
  • Aro Biotherapeutics grew their employee count by -11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$3.3M21-5%N/AN/A
#3
$1.4M90%N/AN/A
#4
$2.3M1525%N/AN/A
#5
$10.5M681%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4.8M31-11%N/AN/A
#8
$1.6M1011%N/AN/A
#9
$7.4M48-11%N/AN/A
#10
$1.9M12-25%N/AN/A
Add Company

Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.

keywords:N/A

$101M

Total Funding

56

Number of Employees

$4.3M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aro Biotherapeutics News

2022-04-17 - Pharmacy Research Excellence Day 2022 | College of ...

Tortorici is the Vice President, Clinical Pharmacology & Non-Clinical Development at Aro Biotherapeutics, and an Advisory Council Member for the...

2022-03-30 - Aro Biotherapeutics to Highlight Therapeutic Potential of ...

Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.4M5630%N/A
#2
$3.5M5614%N/A
#3
$6.6M56N/AN/A
#4
N/A5612%N/A
#5
$221.1M56-2%N/A